Role of Nanotechnology in Psychiatry
Abstract
The field of psychiatry has undergone a rapid transformation in recent years due to continuous advancements across related fields, such as neuroscience, molecular biology, and digital health. These modern approaches often challenge the traditional symptom-based diagnostics that many psychiatrists have been using for decades. Several deficiencies have been evident in traditional psychiatric treatments, such as a lack of precise drug treatment, slow therapeutic development, drug side effects, a virtual absence of disease markers, and a limited understanding of variation in disease. With the continuous development of nanotechnology over the last two decades, researchers have developed new tools to address these issues, including precise and targeted drugs, enhanced diagnostic accuracy, and real-time monitoring. This editorial describes recent contributions and the role of nanotechnology in developing novel psychiatric treatments, including psychopharmacology, diagnosis, neuroprotection, and personalized medicine.
Downloads
References
2. McDaid, D., et al., Understanding the costs and economic impact of mental disorders in South Asia: A systematic review. Asian Journal of Psychiatry, 2024. 102: p. 104239.
3. Kirkbride, J.B., et al., The social determinants of mental health and disorder: evidence, prevention and recommendations. World Psychiatry, 2024. 23(1): p. 58-90.
4. Newson, J.J., D. Hunter, and T.C. Thiagarajan, The Heterogeneity of Mental Health Assessment. Front Psychiatry, 2020. 11: p. 76.
5. Roefs, A., et al., A new science of mental disorders: Using personalised, transdiagnostic, dynamical systems to understand, model, diagnose and treat psychopathology. Behaviour Research and Therapy, 2022. 153: p. 104096.
6. Wu, D., et al., The blood–brain barrier: Structure, regulation and drug delivery. Signal Transduction and Targeted Therapy, 2023. 8(1): p. 217.
7. Upadhyay, R.K., Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int, 2014. 2014: p. 869269.
8. Islam, S., et al., Advances in nanoparticles in targeted drug delivery–A review. Results in Surfaces and Interfaces, 2025. 19: p. 100529.
9. Kim, M., et al., Transformative Impact of Nanocarrier-Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons. Small Science, 2024. 4(11): p. 2400280.
10. Menge, J., et al., Engineering the biophysical properties of lipid nanostructures for drug delivery. Communications Materials, 2026. 7(1): p. 25.
11. Andrade, C. and N.S. Rao, How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian J Psychiatry, 2010. 52(4): p. 378-86.
12. Feng, X., P. Jia, and D. Zhang, Nanocarrier drug delivery system: promising platform for targeted depression therapy. Front Pharmacol, 2024. 15: p. 1435133.
13. Wilar, G., et al., Nanoparticle-Based Drug Delivery Systems Enhance Treatment of Cognitive Defects. Int J Nanomedicine, 2024. 19: p. 11357-11378.
14. Cobos-Puc, L.E., et al., Nanoparticle-Based Strategies to Enhance Catecholaminergic Drug Delivery for Neuropsychiatric Disorders: Advances, Challenges, and Therapeutic Opportunities. Future Pharmacology, 2025. 5(3): p. 51.
15. Gaebel, W., J. Zielasek, and H.R. Cleveland, Psychiatry as a medical specialty: challenges and opportunities. World Psychiatry, 2010. 9(1): p. 36-8.
16. Bakhshpour-Yücel, M., et al., Nanomaterial-Based Sensing Systems to Detect Neuropharmaceutical Compounds and Neurotransmitters. Sensors (Basel), 2025. 25(11).
17. Omiyale, B.O., et al., Nanosensors as diagnostic tools: emerging concepts, opportunities, and design barriers. Analytical Methods, 2026. 18(2): p. 238-281.
18. Hanif, S., et al., Nanotechnology-Based Strategies for Early Diagnosis of Central Nervous System Disorders. Advanced NanoBiomed Research, 2021. 1(10): p. 2100008.
19. Nunes, P.I.G., et al., Mitochondria, Oxidative Stress, and Psychiatric Disorders: An Integrative Perspective on Brain Bioenergetics. Clinical Bioenergetics, 2025. 1(1): p. 6.
20. Sim, T.M., et al., Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders. Int J Mol Sci, 2020. 21(17).
21. Dargude, S., A. Chabukswar, and S. Jagdale, Breaking the brain barrier: Hybrid nanoparticle-enabled delivery for next-gen neurotherapeutics. Hybrid Advances, 2025. 11: p. 100513.
22. Wasti, S., et al., Ethical and legal challenges in nanomedical innovations: a scoping review. Front Genet, 2023. 14: p. 1163392.
23. Abhinav, V., et al., Advancements in Wearable and Implantable BioMEMS Devices: Transforming Healthcare Through Technology. Micromachines (Basel), 2025. 16(5).
24. Badr, J., A. Motulsky, and J.-L. Denis, Digital health technologies and inequalities: A scoping review of potential impacts and policy recommendations. Health Policy, 2024. 146: p. 105122.
Copyright (c) 2026 Journal of Pakistan Psychiatric Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © JPPS. Published by Pakistan Psychiatric Society
Licensing: This work is licensed under Creative Commons Attribution-NonCommercial 4.0 International License
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purposes. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
.png)
